What is S100 Protein? S100 proteins are a family of calcium-binding proteins found in various tissues, with S100B being the most clinically relevant. S100B is primarily expressed in astrocytes and is a biomarker for brain injury, neurodegenerative diseases, and certain cancers (e.g., melanoma). Elevated S100B levels in blood or cerebrospinal fluid indicate tissue damage or disease activity.
Definition: The S100 Protein Unit Converter converts S100 protein concentrations between various units, enabling standardization of laboratory results for clinical and research use.
Purpose: It assists clinicians and researchers in interpreting S100 protein levels across different measurement units (e.g., ng/mL to µg/L), ensuring accurate diagnosis and monitoring of neurological and oncological conditions.
Converting S100 protein concentrations between units is critical for:
Elevated Levels: High S100B levels are associated with traumatic brain injury, stroke, Alzheimer’s disease, and melanoma. Levels may also rise in other conditions like cardiac arrest or sepsis.
Normal Ranges:
Interferences:
Q: Why are there different units for S100 protein?
A: Different units reflect varying standards; ng/mL and µg/L are commonly used in clinical and research settings.
Q: What is a normal S100B level?
A: Normal serum S100B is typically < 0.15 µg/L (< 150 ng/L). Levels vary by sample and context—consult a healthcare provider for interpretation.
Q: Can this converter be used for other biomarkers?
A: No, this converter is specific to S100 protein; other biomarkers have different conversion factors—consult a healthcare provider for accuracy.